{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:12:52Z","timestamp":1758823972392},"reference-count":22,"publisher":"Oceanside Publications Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"Background:<\/jats:bold> Specific antibody deficiency is a primary immunodeficiency characterized by normal immunoglobulins with an inadequate response to polysaccharide antigen vaccination. This disease can result in recurrent infections, the most common being sinopulmonary infections.\n Treatment options include clinical observation, prophylactic antibiotic therapy, and immunoglobulin supplementation therapy, each with limited clinical data about their efficacy. Objective:<\/jats:bold> This study aimed to identify whether there was a statistically significant difference\n in the rate of infections for patients who were managed with clinical observation, prophylactic antibiotics, or immunoglobulin supplementation therapy. Methods:<\/jats:bold> A retrospective chart review was conducted. Patients were eligible for the study if they had normal immunoglobulin\n levels, an inadequate antibody response to polysaccharide antigen\u2010based vaccination, and no other known causes of immunodeficiency. Results:<\/jats:bold> A total of 26 patients with specific antibody deficiency were identified. Eleven patients were managed with immunoglobulin\n supplementation, ten with clinical observation, and five with prophylactic antibiotic therapy. The frequency of antibiotic prescriptions was assessed for the first year after intervention. A statistically significant rate of decreased antibiotic prescriptions after intervention was found for\n patients treated with immunoglobulin supplementation (n = 11<\/jats:italic>; p = 0.0004<\/jats:italic>) and for patients on prophylactic antibiotics (n = 5<\/jats:italic>; p = 0.01<\/jats:italic>). There was no statistical difference in antibiotic prescriptions for those patients treated with immunoglobulin supplementation\n versus prophylactic antibiotics (p = 0.21<\/jats:italic>). Conclusion:<\/jats:bold> Prophylactic antibiotics seemed to be equally effective as immunoglobin supplementation therapy for the treatment of specific antibody deficiency. Further studies are needed in this area.<\/jats:p>","DOI":"10.2500\/aap.2021.42.200086","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T14:00:25Z","timestamp":1609941625000},"page":"87-92","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of management options for specific antibody deficiency"],"prefix":"10.2500","volume":"42","author":[{"given":"Aarti","family":"Pandya","sequence":"first","affiliation":[{"name":"From the Section of Allergy, Asthma and Immunology, Children's Mercy Hospital, Kansas City, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Burgen","sequence":"additional","affiliation":[{"name":"Center for Medical Informatics and Enterprise Analytics, University of Kansas Medical Center, Kansas City, Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. John","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Medical Informatics and Enterprise Analytics, University of Kansas Medical Center, Kansas City, Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Hobson","sequence":"additional","affiliation":[{"name":"Section of Allergy, Clinical Immunology and Rheumatology, University of Kansas Medical Center, Kansas City, Kansas, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Nguyen","sequence":"additional","affiliation":[{"name":"From the Section of Allergy, Asthma and Immunology, Children's Mercy Hospital, Kansas City, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arman","family":"Pirzad","sequence":"additional","affiliation":[{"name":"Division of Allergy, Asthma and Clinical Immunology, University of Colorado, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadia","family":"Hayat Khan","sequence":"additional","affiliation":[{"name":"Section of Allergy, Clinical Immunology and Rheumatology, University of Kansas Medical Center, Kansas City, Kansas, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1081-1206(10)62736-6","article-title":"Distribution of primary immunodeficiency diseases diagnosed in a pediatric tertiary hospital","volume":"84","author":"Javier","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B3","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3389\/fimmu.2019.00986","article-title":"A critical view of specific antibody deficiencies","volume":"10","author":"Sorensen","year":"2019","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.anai.2019.08.012","article-title":"Antibody deficiency testing for primary immunodeficiency: a practical review for the clinician","volume":"123","author":"Marsh","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1183\/09031936.05.00073204","article-title":"Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology","volume":"25","author":"van Kessel","year":"2005","journal-title":"Eur Respir J"},{"key":"B6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaci.2017.12.980","article-title":"Update: vaccines in primary immunodeficiency","volume":"141","author":"Bonilla","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fimmu.2017.00586","article-title":"Specific antibody deficiency: controversies in diagnosis and management","volume":"8","author":"Perez","year":"2017","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaip.2019.01.024","article-title":"Specific antibody deficiencies in clinical practice","volume":"7","author":"Sorensen","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2500\/ajra.2011.25.3653","article-title":"Characterization of specific antibody deficiency in adults with medically refractory chronic rhinosinusitis","volume":"25","author":"Carr","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"B11","first-page":"1","article-title":"Prophylactic antibiotics versus immunoglobulin replacement in specific antibody deficiency","volume":"40","author":"Hajjar","year":"2019","journal-title":"J Clin Immunol"},{"issue":"3","key":"B12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/pai.1998.12.183","article-title":"Natural history of selective antibody deficiency to bacterial polysaccharide antigens in children","volume":"12","author":"Wolpert","year":"1998","journal-title":"Pediatric Asthma, Allergy & Immunology"},{"key":"B13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/cei.12053","article-title":"Specific antibody deficiency in children with recurrent respiratory infections: a controlled study with follow-up","volume":"172","author":"Ruuskanen","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaip.2014.09.022","article-title":"Clinical characteristics of adults with chronic rhinosinusitis and specific antibody deficiency","volume":"3","author":"Kashani","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1081-1206(10)60794-6","article-title":"Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome","volume":"97","author":"Cheng","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B16","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1111\/trf.15020","article-title":"Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy","volume":"58","author":"Gernez","year":"2018","journal-title":"Transfusion"},{"key":"B17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12026-011-8241-y","article-title":"Global study of primary immunodeficiency diseases (PI)\u2014diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation","volume":"51","author":"Modell","year":"2011","journal-title":"Immunol Res"},{"key":"B18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1586\/1744666X.2015.1029457","article-title":"Economic burden of common variable immunodeficiency: annual cost of disease","volume":"11","author":"Sadeghi","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"33037","DOI":"10.12788\/jhm.3106","article-title":"Screening for humoral immunodeficiency in patients with community-acquired pneumonia","volume":"14","author":"Vadamalai","year":"2019","journal-title":"J Hosp Med"},{"key":"B20","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/j.1572-0241.1998.00545.x","article-title":"A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis","volume":"93","author":"Das","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.iac.2015.07.003","article-title":"Specific antibody deficiencies","volume":"35","author":"Wall","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"B22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaip.2017.11.024","article-title":"Should antibiotic prophylaxis be routinely used in patients with antibody-mediated primary immunodeficiency?","volume":"6","author":"Ballow","year":"2018","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2021\/00000042\/00000001\/art00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T04:45:14Z","timestamp":1611636314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2021.42.200086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,1]]}},"alternative-id":["1088-5412(20210101)42:1L.87;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2021.42.200086","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}